Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs » Metformin

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Metformin Safe for Patients with Advanced Heart Failure and Diabetes Posted: Sunday, January 17, 2010

A new study has shown that metformin, is safe for use in treating patients who have both diabetes and advanced heart failure.

EASD: Metformin Protects against Cancer in Type 2 Diabetes Posted: Wednesday, October 07, 2009

Metformin was found to reduce risk in pancreatic and colon cancers in patients with Type 2 diabetes in an epidemiologic study.

EASD: New First in Class Drug Effective in Phase III Trial Posted: Wednesday, October 07, 2009

An investigational drug targeting an insulin-independent pathway in Type 2 diabetes produced early and substantial reductions in blood glucose and body weight in a phase III study.

Early Triple Therapy for Type 2 Diabetes Posted: Wednesday, September 23, 2009

When metformin and a sulfonylurea or a glinide fail to bring Type 2 diabetes under control, adding pioglitazone may do the trick, French research suggests.

Insulin or Metformin Does Not Reduce Inflammatory Biomarkers Posted: Wednesday, September 16, 2009

In patients with recent onset Type 2 diabetes, treatment with insulin or the diabetes drug metformin did not reduce inflammatory biomarkers, such as high-sensitivity C-reactive protein, although the treatment did improve glucose control, according to a study.

Insulin as First Therapy for Type 2 Diabetes: Study Posted: Wednesday, September 09, 2009

Insulin can be safely and effectively used as a first-line treatment, in combination with metformin, in patients with newly diagnosed Type 2 diabetes, with high rates of patient satisfaction and compliance, results of a study indicate.

Certain Diabetes Therapies May be Associated with Pancreatic Cancer Risks Posted: Wednesday, August 26, 2009

Metformin appears to reduce the risk for pancreatic cancer in patients with diabetes, whereas insulin therapy appears to increase the risk, according to the results of a large case-control study.

Metformin Lowers Risk for Pancreatic Cancer Posted: Wednesday, August 12, 2009

Metformin, one of the most widely used diabetes drugs, may offer patients the added benefit of lowering their odds for pancreatic cancer by 62%, a new study shows.

Study Finds Common Diabetic Therapy Reduces Risk of Pancreatic Cancer Posted: Wednesday, August 05, 2009

Research suggests promising chemopreventive role for metformin by reducing the risk of pancreatic cancer by 62 percent.

Metformin + Viagra More Effective Treatment for Erectile Function Posted: Wednesday, June 24, 2009

Insulin-resistant men had significant improvement in erectile function when metformin was added to sildenafil (Viagra), according to data from a small clinical study. Metformin increases the activity of sildenafil.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.